NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

On your three points:

1) Saying that NWBO's failure in general to not update the US clinical trial registry is not the subject is odd. The issue being asserted is if NWBO is required to update it. I know they do not.

2) Is about "primary completion date", not results submission. They are unrelated. The primary completion date was known months prior to Oct 5, 2020. This was a required update in one month having nothing to do with results submission.

3) This one can be argued. But the protocol change was publicly known to patients. Does that count as communicated?